Spero Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Spero Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Spero Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -1.04 %, a 74.3% increase year-over-year.
  • Spero Therapeutics, Inc. annual Operating Margin for 2023 was 20.7 %.
  • Spero Therapeutics, Inc. annual Operating Margin for 2022 was -78.9 %, a 83.6% increase from 2021.
  • Spero Therapeutics, Inc. annual Operating Margin for 2021 was -482 %, a 43.2% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 20.7 +99.6 Jan 1, 2023 Dec 31, 2023
2022 -78.9 +403 +83.6% Jan 1, 2022 Dec 31, 2022
2021 -482 +366 +43.2% Jan 1, 2021 Dec 31, 2021
2020 -848 -500 -143% Jan 1, 2020 Dec 31, 2020
2019 -348 +731 +67.7% Jan 1, 2019 Dec 31, 2019
2018 -1.08K +1.03K +48.8% Jan 1, 2018 Dec 31, 2018
2017 -2.11K +7.81K +78.7% Jan 1, 2017 Dec 31, 2017
2016 -9.92K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.